News

Leveragen and Moderna link to advance therapeutics

Leveragen and Moderna have entered a research, option and licence agreement to advance the development of various therapeutics. The multi-target deal will utilise Leveragen’s fully human single-domain antibody discovery platform for therapeutic advancement. Leveragen...